Children’s Triaminic Cough Patch Is Recalled
From Times Wire Reports
A patch version of the Triaminic children’s cough and cold medicine is being recalled by its manufacturer after some youngsters swallowed the product and suffered seizures.
There have been eight reports of accidental ingestion, including a case of a Canadian child with seizures, said Julie Masow, a spokeswoman for the Switzerland-based drug maker Novartis. Masow said more than 50 million patches had been sold in the U.S., Canada, Mexico and Central America since they went on the market in 2000.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
